VistaGen Therapeutics Receives AV-101 Japanese Patent for Treatment of Depression and Hyperalgesia Feb 19, 2019
VistaGen Therapeutics Receives Notice of Allowance for U.S. Patent for Treatment of Depression with PH10 Feb 13, 2019
VistaGen Therapeutics to Present at the 21st Annual BIO CEO & Investor Conference on February 11, 2019 Feb 5, 2019
VistaGen Therapeutics Appoints Pharmaceutical Industry Veteran, Ann Cunningham, to its Board of Directors Jan 15, 2019
VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of Depression Nov 12, 2018
